Retatrutide 30mg (Research Grade)
Overview
Retatrutide is a novel multi-receptor agonist currently being studied for its interaction with metabolic pathways involving GLP-1, GIP, and glucagon receptors. This triple-agonist profile makes it a subject of increasing interest in research focused on energy balance, metabolic regulation, and body composition.
Key Research Areas
- Metabolic pathway modulation (GLP-1, GIP, glucagon receptors)
- Appetite signaling and satiety mechanisms
- Energy expenditure and fat metabolism
- Glucose regulation pathways
- Body composition and weight-related research models
Mechanism of Interest
Retatrutide is unique due to its triple receptor activity, targeting:
- GLP-1 (glucagon-like peptide-1)
- GIP (glucose-dependent insulinotropic polypeptide)
- Glucagon receptors
This combined activity is being explored for its potential to influence both caloric intake and energy expenditure in research settings.
Why Retatrutide?
Compared to single or dual agonists, Retatrutide is being studied for its broader metabolic interaction profile. Early-stage research suggests enhanced effects in areas of metabolic efficiency and body composition analysis.
Administration (Research Context Only)
This compound is commonly studied using:
- Subcutaneous (SubQ)
Protocol and dosing vary depending on research design and model.
Product Details
- Purity: Research Grade
- Form: Lyophilized peptide
- Size: 30mg vial
- Stability: Store refrigerated before and after reconstitution
Important Disclaimer
This product is intended for laboratory research purposes only.
Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
Quality Assurance
Each batch undergoes strict quality control processes to ensure consistency, purity, and reliability for research applications.
Reviews
There are no reviews yet.